TSRO Announce 2. Y Partnership w. Foundation Women’s cancer
Oct 18, 2017 13:28:42 GMT
miamianne67 likes this
Post by tomsylver on Oct 18, 2017 13:28:42 GMT
The Foundation for Women’s Cancer and TESARO Announce 2nd Year of Partnership Supporting the National Race to End Women’s Cancer
CHICAGO and WALTHAM, Mass., Oct. 18, 2017 (GLOBE NEWSWIRE) -- The Foundation for Women’s Cancer (FWC), the official foundation of the Society of Gynecologic Oncology, and TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the continuation of their partnership supporting the annual National Race to End Women’s Cancer. TESARO is the Presenting Break-Through Sponsor of the 8th annual National Race to End Women’s Cancer, the FWC’s pinnacle awareness and fundraising event, bringing families and friends from across the country together to support women with gynecologic cancers. The event features a 5K run and 1 mile walk on Sunday, Nov. 5, along Pennsylvania Avenue, NW in Washington, D.C.
“Our ongoing relationship with TESARO reflects our shared commitment to support women with gynecologic cancers,” said David G. Mutch, MD, Chairman of FWC’s Board of Directors. “We are grateful for TESARO’s continued support and dedication to making the Race a memorable event for the survivors, advocates, and loved ones.”
“TESARO strives to keep patients at the heart of everything we do and is committed to being a partner of choice with the gynecologic cancer community. We are honored to support this incredible event and the important work that the FWC does to raise awareness and provide support to those touched by cancer,” said Lonnie Moulder, CEO of TESARO. “Our team is proud to be a part of this unique weekend of education, advocacy, support and inspiration.”
Every five minutes a woman will receive a gynecologic cancer diagnosis in the United States. More than 107,470 women will be diagnosed with a gynecologic cancer and about 31,600 will die from these cancers in 2017. The FWC supports survivors and works to raise awareness and research funding to eradicate gynecologic cancers.
Pre-race programing will begin at 7:30 a.m. at 14th Street and Pennsylvania Avenue NW, with the 5K run starting at 9:30 a.m., followed by the 1 mile walk at 9:45 a.m. FWC anticipates approximately 2,000 participants at this year’s event.
The event is led by National Race Co-Chairs Camille Grammer, an endometrial cancer survivor and star on “The Real Housewives of Beverly Hills,” who will walk the route with her team, “Camille’s Crusaders;” and Wendy Ericsson, a uterine cancer survivor, who also serves as captain of her team “Wendy’s Warriors.” Individuals and teams can register at endwomenscancer.org.
About TESARO
TESARO is an oncology-focused biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer. For more information, visit www.tesarobio.com, and follow us on Twitter and LinkedIn.
About the National Race to End Women’s Cancer
The race started more than eight years ago as a pinnacle fundraising and awareness event for the Foundation for Women’s Cancer. It serves as an opportunity to bring families and friends together to support women with gynecologic cancers. Today more than $700,000 from the race has been raised with more than 20,000 participants from survivors, advocates and families attending the race from across the country.
Join the Movement and Follow Us on Social Media:
Facebook.com/NationalRacetoEndWomensCancer
Twitter.com/GYNCancer
Instagram.com/foundationforwomenscancer
#EndWomensCancer
CONTACTS:
For TESARO:
Jennifer Davis
Vice President, Corporate Communications & Investor Relations
+1.781.325.1116 or jdavis@tesarobio.com
For National Race to End Women’s Cancer:
Kerry Lynn Bohen
Vice President, Brotman Winter Fried
+1.202.468.8300 or kbohen@aboutbwf.com
CHICAGO and WALTHAM, Mass., Oct. 18, 2017 (GLOBE NEWSWIRE) -- The Foundation for Women’s Cancer (FWC), the official foundation of the Society of Gynecologic Oncology, and TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the continuation of their partnership supporting the annual National Race to End Women’s Cancer. TESARO is the Presenting Break-Through Sponsor of the 8th annual National Race to End Women’s Cancer, the FWC’s pinnacle awareness and fundraising event, bringing families and friends from across the country together to support women with gynecologic cancers. The event features a 5K run and 1 mile walk on Sunday, Nov. 5, along Pennsylvania Avenue, NW in Washington, D.C.
“Our ongoing relationship with TESARO reflects our shared commitment to support women with gynecologic cancers,” said David G. Mutch, MD, Chairman of FWC’s Board of Directors. “We are grateful for TESARO’s continued support and dedication to making the Race a memorable event for the survivors, advocates, and loved ones.”
“TESARO strives to keep patients at the heart of everything we do and is committed to being a partner of choice with the gynecologic cancer community. We are honored to support this incredible event and the important work that the FWC does to raise awareness and provide support to those touched by cancer,” said Lonnie Moulder, CEO of TESARO. “Our team is proud to be a part of this unique weekend of education, advocacy, support and inspiration.”
Every five minutes a woman will receive a gynecologic cancer diagnosis in the United States. More than 107,470 women will be diagnosed with a gynecologic cancer and about 31,600 will die from these cancers in 2017. The FWC supports survivors and works to raise awareness and research funding to eradicate gynecologic cancers.
Pre-race programing will begin at 7:30 a.m. at 14th Street and Pennsylvania Avenue NW, with the 5K run starting at 9:30 a.m., followed by the 1 mile walk at 9:45 a.m. FWC anticipates approximately 2,000 participants at this year’s event.
The event is led by National Race Co-Chairs Camille Grammer, an endometrial cancer survivor and star on “The Real Housewives of Beverly Hills,” who will walk the route with her team, “Camille’s Crusaders;” and Wendy Ericsson, a uterine cancer survivor, who also serves as captain of her team “Wendy’s Warriors.” Individuals and teams can register at endwomenscancer.org.
About TESARO
TESARO is an oncology-focused biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer. For more information, visit www.tesarobio.com, and follow us on Twitter and LinkedIn.
About the National Race to End Women’s Cancer
The race started more than eight years ago as a pinnacle fundraising and awareness event for the Foundation for Women’s Cancer. It serves as an opportunity to bring families and friends together to support women with gynecologic cancers. Today more than $700,000 from the race has been raised with more than 20,000 participants from survivors, advocates and families attending the race from across the country.
Join the Movement and Follow Us on Social Media:
Facebook.com/NationalRacetoEndWomensCancer
Twitter.com/GYNCancer
Instagram.com/foundationforwomenscancer
#EndWomensCancer
CONTACTS:
For TESARO:
Jennifer Davis
Vice President, Corporate Communications & Investor Relations
+1.781.325.1116 or jdavis@tesarobio.com
For National Race to End Women’s Cancer:
Kerry Lynn Bohen
Vice President, Brotman Winter Fried
+1.202.468.8300 or kbohen@aboutbwf.com